As a proliferation marker, the Ki-67 index is used clinically to determine the prognosis of cancer and evaluate its treatment, and it is of great importance to decision-making concerning the adjuvant treatment of early breast cancer [2]. The gene discussed is MKI67; the disease is breast cancer.